Sein Medical will be strategically positioned to cater to a diverse range of stakeholders in the healthcare industry, including private clinics, individuals, imaging labs, hospitals, and research facilities. The Company will offer its products and services through various distribution channels, such as private screening services, partnership with private clinics and public sector hospitals and royalties from licensing deals with mammography OEMs across Canada.

Sein Medical will stand out from its competitors through its innovative approach and advanced technologies. The Company’s use of proprietary biomarker panels and AI integration will ensure precision and personalized treatment for patients, setting it apart in the market. The Company’s pioneering technology and data-driven approach will enable healthcare providers to make informed decisions, leading to better patient outcomes. Additionally, the company’s user-friendly application will make it easy for healthcare professionals to integrate into their existing workflows, saving time and resources. With a cost-effective solution and a commitment to innovation, Sein Medical will be a valuable addition to the
Canadian healthcare industry, poised to elevate the standard of care for breast cancer detection and treatment.